Literature DB >> 14712331

Sequence, evolution and ligand binding properties of mammalian Duffy antigen/receptor for chemokines.

Christophe Tournamille1, Antoine Blancher, Caroline Le Van Kim, Pierre Gane, Pol André Apoil, Wilson Nakamoto, Jean Pierre Cartron, Yves Colin.   

Abstract

The Duffy antigen/ receptor for chemokine, DARC, acts as a widely expressed promiscuous chemokine receptor and as the erythrocyte receptor for Plasmodium vivax. To gain insight into the evolution and structure/function relations of DARC, we analyzed the binding of anti-human Fy monoclonal antibodies (mAbs) and human chemokines to red blood cells (RBCs) from 11 nonhuman primates and two nonprimate mammals, and we elucidated the structures of the DARC genes from gorilla, gibbon, baboon, marmoset, tamarin, night monkey and cattle. CXCL-8 and CCL-5 chemokine binding analysis indicated that the promiscuous binding profile characteristic of DARC is conserved across species. Among three mAbs that detected the Fy6 epitope by flow cytometric analysis of human and chimpanzee RBCs, only one reacted with night monkey and squirrel monkey. Only chimpanzee RBCs bound a significant amount of the anti-Fy3 mAb. Fy3 was also poorly detected on RBCs from gorilla, baboon and rhesus monkey, but not from new world monkeys. Alignment of DARC homologous sequences allowed us to construct a phylogenetic tree in which all branchings were in accordance with current knowledge of primate phylogeny. Although DARC was expected to be under strong internal and external selection pressure, in order to maintain chemokine binding and avoid Plasmodium vivax binding, respectively, our present study did not provide arguments in favor of a selection pressure on the extracellular domains involved in ligand specificity. The amino acid variability of DARC-like polypeptides was found to be well correlated with the hydrophilicity indexes, with the highest divergence on the amino-terminal extracellular domain. Analysis of the deduced amino acid sequences highlighted the conservation of some amino acid residues, which should prove to be critical for the structural and functional properties of DARC.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14712331     DOI: 10.1007/s00251-003-0633-2

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  54 in total

1.  Cloning, characterization, and mapping of a murine promiscuous chemokine receptor gene: homolog of the human Duffy gene.

Authors:  H Luo; A Chaudhuri; K R Johnson; K Neote; V Zbrzezna; Y He; A O Pogo
Journal:  Genome Res       Date:  1997-09       Impact factor: 9.043

2.  The neighbor-joining method: a new method for reconstructing phylogenetic trees.

Authors:  N Saitou; M Nei
Journal:  Mol Biol Evol       Date:  1987-07       Impact factor: 16.240

3.  Molecular basis and PCR-DNA typing of the Fya/fyb blood group polymorphism.

Authors:  C Tournamille; C Le Van Kim; P Gane; J P Cartron; Y Colin
Journal:  Hum Genet       Date:  1995-04       Impact factor: 4.132

4.  The Duffy antigen receptor for chemokines is up-regulated during acute renal transplant rejection and crescentic glomerulonephritis.

Authors:  S Segerer; H Regele; M MacK; R Kain; J P Cartron; Y Colin; D Kerjaschki; D Schlöndorff
Journal:  Kidney Int       Date:  2000-10       Impact factor: 10.612

5.  Positive Darwinian selection after gene duplication in primate ribonuclease genes.

Authors:  J Zhang; H F Rosenberg; M Nei
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

6.  The coding sequence of Duffy blood group gene in humans and simians: restriction fragment length polymorphism, antibody and malarial parasite specificities, and expression in nonerythroid tissues in Duffy-negative individuals.

Authors:  A Chaudhuri; J Polyakova; V Zbrzezna; A O Pogo
Journal:  Blood       Date:  1995-02-01       Impact factor: 22.113

Review 7.  Sequence alignment of the G-protein coupled receptor superfamily.

Authors:  W C Probst; L A Snyder; D I Schuster; J Brosius; S C Sealfon
Journal:  DNA Cell Biol       Date:  1992 Jan-Feb       Impact factor: 3.311

8.  Plasmodium vivax interaction with the human Duffy blood group glycoprotein: identification of a parasite receptor-like protein.

Authors:  S P Wertheimer; J W Barnwell
Journal:  Exp Parasitol       Date:  1989-11       Impact factor: 2.011

9.  A new human Duffy blood group specificity defined by a murine monoclonal antibody. Immunogenetics and association with susceptibility to Plasmodium vivax.

Authors:  M E Nichols; P Rubinstein; J Barnwell; S Rodriguez de Cordoba; R E Rosenfield
Journal:  J Exp Med       Date:  1987-09-01       Impact factor: 14.307

Review 10.  Biological roles of oligosaccharides: all of the theories are correct.

Authors:  A Varki
Journal:  Glycobiology       Date:  1993-04       Impact factor: 4.313

View more
  23 in total

Review 1.  In silico studies on DARC.

Authors:  Alexandre G de Brevern; Ludovic Autin; Yves Colin; Olivier Bertrand; Catherine Etchebest
Journal:  Infect Disord Drug Targets       Date:  2009-06

2.  Molecular evolution of a malaria resistance gene (DARC) in primates.

Authors:  Thiago Yukio Kikuchi Oliveira; Eugene E Harris; Diogo Meyer; Chong K Jue; Wilson Araújo Silva
Journal:  Immunogenetics       Date:  2012-03-07       Impact factor: 2.846

3.  Strict tropism for CD71+/CD234+ human reticulocytes limits the zoonotic potential of Plasmodium cynomolgi.

Authors:  Varakorn Kosaisavee; Rossarin Suwanarusk; Adeline C Y Chua; Dennis E Kyle; Benoit Malleret; Rou Zhang; Mallika Imwong; Rawiwan Imerbsin; Ratawan Ubalee; Hugo Sámano-Sánchez; Bryan K S Yeung; Jessica J Y Ong; Eric Lombardini; François Nosten; Kevin S W Tan; Pablo Bifani; Georges Snounou; Laurent Rénia; Bruce Russell
Journal:  Blood       Date:  2017-07-11       Impact factor: 22.113

Review 4.  The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis.

Authors:  Daniel J Brat; Anita C Bellail; Erwin G Van Meir
Journal:  Neuro Oncol       Date:  2005-04       Impact factor: 12.300

5.  Fy(a)/Fy(b) antigen polymorphism in human erythrocyte Duffy antigen affects susceptibility to Plasmodium vivax malaria.

Authors:  Christopher L King; John H Adams; Jia Xianli; Brian T Grimberg; Amy M McHenry; Lior J Greenberg; Asim Siddiqui; Rosalind E Howes; Monica da Silva-Nunes; Marcelo U Ferreira; Peter A Zimmerman
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-28       Impact factor: 11.205

6.  Plasmodium vivax clinical malaria is commonly observed in Duffy-negative Malagasy people.

Authors:  Didier Ménard; Céline Barnadas; Christiane Bouchier; Cara Henry-Halldin; Laurie R Gray; Arsène Ratsimbasoa; Vincent Thonier; Jean-François Carod; Olivier Domarle; Yves Colin; Olivier Bertrand; Julien Picot; Christopher L King; Brian T Grimberg; Odile Mercereau-Puijalon; Peter A Zimmerman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-15       Impact factor: 11.205

7.  A monkey's tale: the origin of Plasmodium vivax as a human malaria parasite.

Authors:  Ananias A Escalante; Omar E Cornejo; Denise E Freeland; Amanda C Poe; Ester Durrego; William E Collins; Altaf A Lal
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-31       Impact factor: 11.205

Review 8.  Red blood cell polymorphism and susceptibility to Plasmodium vivax.

Authors:  Peter A Zimmerman; Marcelo U Ferreira; Rosalind E Howes; Odile Mercereau-Puijalon
Journal:  Adv Parasitol       Date:  2013       Impact factor: 3.870

9.  The Duffy-null state is associated with a survival advantage in leukopenic HIV-infected persons of African ancestry.

Authors:  Hemant Kulkarni; Vincent C Marconi; Weijing He; Michael L Landrum; Jason F Okulicz; Judith Delmar; Dickran Kazandjian; John Castiblanco; Seema S Ahuja; Edwina J Wright; Robin A Weiss; Robert A Clark; Matthew J Dolan; Sunil K Ahuja
Journal:  Blood       Date:  2009-07-20       Impact factor: 22.113

10.  Opposing roles of murine duffy antigen receptor for chemokine and murine CXC chemokine receptor-2 receptors in murine melanoma tumor growth.

Authors:  Linda W Horton; Yingchun Yu; Snjezana Zaja-Milatovic; Robert M Strieter; Ann Richmond
Journal:  Cancer Res       Date:  2007-10-15       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.